Seattle Genetics Inc (NASDAQ:SGEN)

43.16
Delayed Data
As of May 28
 +0.66 / +1.55%
Today’s Change
30.05
Today|||52-Week Range
44.95
+34.33%
Year-to-Date

Today’s Trading

Previous close42.50
Today’s open42.36
Day’s range41.86 - 43.57
Volume970,601
Average volume (3 months)1,157,764
Market cap$5.3B
Dividend yield--
Data as of 05/28/2015

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-23.59%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+6.50%
P/E ratioNM
Price/Sales13.83
Price/Book24.99

Competitors

 Today’s
change
Today’s
% change
RCPTReceptos Inc-0.82-0.50%
HZNPHorizon Pharma PLC-0.34-1.04%
AKRXAkorn Inc+1.24+2.82%
ICPTIntercept Pharmaceut...-5.56-2.13%
Data as of 05/28/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$286.8M
Annual profit (last year)-$76.1M
Net profit margin-26.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers